Kui Wang

Kui has a broad experience in gene therapy, RNA technologies, and drug delivery through both academic and industry training. Kui’s current work focuses on developing novel gene editing strategies, as well as advancing and innovating mRNA technologies to enable next-generation therapeutic approaches.